BioSpace News Archive

Pharm Country

atai Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference

atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the Cowen 43rd Annual Health Care Conference.

March 1, 2023
·
1 min read
Biotech Bay

Invitae to Present at the TD Cowen 43rd Annual Health Care Conference

Invitae, a leading medical genetics company, announced that Ken Knight, president and chief executive officer, will participate in a fireside chat at the TD Cowen 43rd Annual Health Care Conference on Monday, March 6, at 1:30 p.m. Eastern.

March 1, 2023
·
1 min read
Pharm Country

Rocket Pharmaceuticals to Participate in the 43rd Annual Cowen Health Care Conference

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) today announced that Gaurav Shah, M.D., Chief Executive Officer, is scheduled to participate in the Genetic Medicines Corporate Panel at the 43rd Annual Cowen Health Care Conference taking place in Boston, MA on Monday, March 6, 2023 at 10:30 a.m. ET.

March 1, 2023
·
5 min read
Business

Certara Reports Fourth Quarter and Full Year 2022 Financial Results

Certara, Inc., a global leader in biosimulation, reported its financial results for the fourth quarter and full year of 2022 and issued guidance for 2023.

March 1, 2023
·
25 min read
Biotech Bay

Dynavax to Present at the Cowen 43rd Annual Health Care Conference

Dynavax Technologies Corporation (Nasdaq: DVAX) today announced that Kelly MacDonald, Chief Financial Officer, will participate in a fireside chat at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, at 2:10 p.m. E.T.

March 1, 2023
·
1 min read
BioMidwest

Paragon 28 to Present at Upcoming March 2023 Investor Conferences

Paragon 28, Inc. announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will be presenting in fireside chats at two upcoming investor conferences.

March 1, 2023
·
1 min read
Business

Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2022 Results; Sets 2023 Guidance

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading provider of surgical services, today announced results for the fourth quarter and full year ended December 31, 2022.

March 1, 2023
·
20 min read
Pharm Country

Protara Therapeutics to Participate in Upcoming Investor Conferences

Protara Therapeutics, Inc. today announced that management will participate in the following upcoming investor conferences.

March 1, 2023
·
1 min read
Biotech Bay

Pliant Therapeutics to Participate in Upcoming Investor Events - March 1, 2023

Pliant Therapeutics, Inc. today announced senior management’s participation at the following investor events in March.

March 1, 2023
·
2 min read
Business

Centessa Pharmaceuticals Announces Addition of Patrick Yue, MD, as Senior Vice President of Clinical Development, Innovative Medicines

Centessa Pharmaceuticals plc today announced the appointment of Patrick Yue, MD, to Centessa’s management team as Senior Vice President of Clinical Development, Innovative Medicines.

March 1, 2023
·
5 min read